We have established the Audit Committee with written terms of reference in compliance with the Code on Corporate Governance Practices, as set out in Appendix C1 to the Listing Rules. The Audit Committee consists of five Directors, being Mr. Ping Cho Terence HON, Mr. George William Hunter CAUTHERLEY, Dr. Chi Ming LEE, Ms. Chi Sau Giselle LEE and Mr. Nan SHEN. The chairperson of the Audit Committee is Mr. Ping Cho Terence HON, who holds the appropriate professional qualifications as required under Rules 3.10(2) and 3.21 of the Listing Rules. The primary duties of the Audit Committee include, among others, the following:
We have established the Remuneration Committee with written terms of reference in compliance with the Corporate Governance Code, as set out in Appendix C1 to the Listing Rules. The Remuneration Committee consists of three Directors, being Dr. Shui On Leung, Dr. Chi Ming LEE and Mr. Ping Cho Terence HON. The chairperson of the Remuneration Committee is Dr. Chi Ming LEE. The primary duties of the Remuneration Committee include, among others, the following:
We have established the Nomination Committee with written terms of reference in compliance with the Code on Corporate Governance Practices, as set out in Appendix C1 to the Listing Rules. The Nomination Committee consists of four Directors, being Dr. Shui On Leung, Mr. Ping Cho Terence HON, Ms. Chi Sau Giselle LEE and Mr. Nan SHEN. The chairperson of the Nomination Committee is Dr. Leung. The primary duties of the Nomination Committee include, among others, the following:
We have established policies embedding the code of conducts for effective whistleblowing and anti-corruption systems. Under the policies, employees and stakeholders can report any serious concerns about suspected fraud, corruption, malpractice, misconduct or irregularity of the Group by email at whistleblower@sinomab.com. This email can only be accessed by Senior Manager – Internal Audit Department or any person as designated by the Audit Committee.
© 2026 SinoMab BioScience Limited. All Rights Reserved.